TREACE MEDICAL CONCEPTS, INC. financial data

Symbol
TMCI on Nasdaq
Location
Ponte Vedra, FL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 387% % -6%
Quick Ratio 108% % 11%
Debt-to-equity 111% % 14%
Return On Equity -62% % -27%
Return On Assets -30% % -19%
Operating Margin -25% % 4.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64,590,503 shares 2.7%
Common Stock, Shares, Outstanding 62,275,371 shares 1.1%
Entity Public Float $265,900,000 USD -14%
Common Stock, Value, Issued $64,000 USD 3.2%
Weighted Average Number of Shares Outstanding, Basic 63,269,003 shares 1.9%
Weighted Average Number of Shares Outstanding, Diluted 63,269,003 shares 1.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $212,690,000 USD 1.6%
Research and Development Expense $20,282,000 USD -1.5%
Selling and Marketing Expense $140,880,000 USD -4.6%
General and Administrative Expense $62,744,000 USD 13%
Operating Income (Loss) $54,154,000 USD 2.8%
Net Income (Loss) Attributable to Parent $59,002,000 USD -5.8%
Earnings Per Share, Basic -0.93 USD/shares -3.3%
Earnings Per Share, Diluted -0.93 USD/shares -3.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,708,000 USD -5.7%
Marketable Securities, Current $37,659,000 USD -41%
Accounts Receivable, after Allowance for Credit Loss, Current $42,155,000 USD 3.3%
Inventory, Net $36,031,000 USD -8.2%
Assets, Current $132,054,000 USD -18%
Property, Plant and Equipment, Net $29,752,000 USD 15%
Operating Lease, Right-of-Use Asset $7,614,000 USD -9.8%
Intangible Assets, Net (Excluding Goodwill) $7,125,000 USD -12%
Goodwill $12,815,000 USD 0%
Other Assets, Noncurrent $1,221,000 USD 200%
Assets $190,581,000 USD -12%
Accounts Payable, Current $6,726,000 USD -36%
Employee-related Liabilities, Current $6,331,000 USD -3.7%
Accrued Liabilities, Current $5,784,000 USD -20%
Liabilities, Current $30,635,000 USD -12%
Operating Lease, Liability, Noncurrent $13,982,000 USD -12%
Other Liabilities, Noncurrent $3,049,000 USD 8141%
Liabilities $103,249,000 USD -0.92%
Accumulated Other Comprehensive Income (Loss), Net of Tax $72,000 USD -26%
Retained Earnings (Accumulated Deficit) $248,992,000 USD -31%
Stockholders' Equity Attributable to Parent $87,332,000 USD -23%
Liabilities and Equity $190,581,000 USD -12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,198,000 USD
Net Cash Provided by (Used in) Financing Activities $282,000 USD -52%
Net Cash Provided by (Used in) Investing Activities $1,894,000 USD -150%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 64,029,378 shares 2.6%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,022,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,708,000 USD -5.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,229,000 USD -6.7%
Deferred Tax Assets, Valuation Allowance $56,671,000 USD 28%
Deferred Tax Assets, Gross $60,342,000 USD 22%
Operating Lease, Liability $14,534,000 USD -11%
Payments to Acquire Property, Plant, and Equipment $3,543,000 USD -9.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $59,027,000 USD -5.8%
Lessee, Operating Lease, Liability, to be Paid $19,951,000 USD -14%
Property, Plant and Equipment, Gross $53,621,000 USD 30%
Operating Lease, Liability, Current $552,000 USD 34%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,097,000 USD -7.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,857,000 USD 1.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.094 pure 1.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,417,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,159,000 USD 2%
Deferred Tax Assets, Operating Loss Carryforwards $38,092,000 USD 35%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,222,000 USD 2%
Additional Paid in Capital $337,371,000 USD 11%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,461,000 USD 29%
Deferred Tax Assets, Net of Valuation Allowance $3,671,000 USD -28%
Share-based Payment Arrangement, Expense $33,823,000 USD 11%
Interest Expense $5,320,000 USD 1.2%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%